Filta Group (LON:FLTA) provides cleaning services to commercial kitchens in North America, the UK and, more recently, mainland Europe. For cleaning and filtering frying machines, this is largely carried out
The Par Syndicate EIS Fund is a discretionary portfolio service, which will provide a portfolio of investments in unquoted technology companies. The manager highlights that it is providing genuine risk
Oxford BioMedica (LON:OXB) is a specialist, advanced therapy, viral-vector biopharmaceutical company. It offers vector manufacturing and development services, while developing proprietary drug candidates. OXB also receives royalties on commercial products
Hardman & Co Analyst Mike Foster joins DirectorsTalk to discuss Secure Income REITs. Mike explains the name of the research report, the companies it covers, the cycle, dividend yields, attraction and
Primary Health Properties (LON:PHP) and MedicX Fund completed an all-share recommended merger on 14 March 2019. The latter is also a UK REIT, investing in assets similar to PHP, focused
DP Poland (LON:DPP) announced FY18 results this morning, which, as previously trailed, were impacted by unseasonally warm weather and competitive marketing activity by delivery aggregators, but still managed 24% growth
Hardman and Co analyst Mark Thomas joins DirectorsTalk to discuss his note on Morses Club(LON:MCL) recent acquisitions. Mark talks about the acquisitions, what Curo does to build the group, the expectant profits,
“Secure income” REITs have created wealth rather than merely preserving it. Through the cycle – even investing in 2007, i.e. at the top – our proxy for “secure real estate
Palace Capital (LON:PCA) is a real estate investor. It has recently commenced construction of its mixed residential and commercial development at Hudson Quarter, having secured a new £26.5m debt facility
Volta Finance Ltd (LON:VTA) Serge Demay, from Fund Manager AXA IM, gave an investor presentation on 7 March. Key takeaways were: (i) Flexible mandate means it can exploit whichever element
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
